AAAAAA

   
Results: 1-7 |
Results: 7
Increased stromal expression of murine urokinase plasminogen activator in a human breast cancer xenograft model following treatment with the matrix metalloprotease inhibitor, batimastat
Authors: Holst-Hansen, C Low, JA Stephens, RW Johnson, MD Carmeliet, P Frandsen, TL Brunner, N Dickson, RB
Citation: C. Holst-hansen et al., Increased stromal expression of murine urokinase plasminogen activator in a human breast cancer xenograft model following treatment with the matrix metalloprotease inhibitor, batimastat, BREAST CANC, 68(3), 2001, pp. 225-237
Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) fin the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model
Authors: Frandsen, TL Holst-Hansen, C Nielsen, BS Christensen, IJ Nyengaard, JR Carmeliet, P Brunner, N
Citation: Tl. Frandsen et al., Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) fin the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model, CANCER RES, 61(2), 2001, pp. 532-537
Peptide-derived antagonists of the urokinase receptor. Affinity maturationby combinatorial chemistry, identification of functional epitopes, and inhibitory effect on cancer cell intravasation
Authors: Ploug, M Ostergaard, S Gardsvoll, H Kovalski, K Holst-Hansen, C Holm, A Ossowski, L Dano, K
Citation: M. Ploug et al., Peptide-derived antagonists of the urokinase receptor. Affinity maturationby combinatorial chemistry, identification of functional epitopes, and inhibitory effect on cancer cell intravasation, BIOCHEM, 40(40), 2001, pp. 12157-12168
Plasma Escherichia coli beta-galactosidase as a marker of tumor burden andresponse to experimental anti-neoplastic therapy in nude mice xenografted with lacZ transduced human tumor cells
Authors: Holst-Hansen, C Stephens, RW Johannessen, BE Jensen, PB Brunner, N
Citation: C. Holst-hansen et al., Plasma Escherichia coli beta-galactosidase as a marker of tumor burden andresponse to experimental anti-neoplastic therapy in nude mice xenografted with lacZ transduced human tumor cells, LAB INV, 80(5), 2000, pp. 719-724
Soluble urokinase receptor released from human carcinoma cells: a plasma parameter for xenograft tumour studies
Authors: Holst-Hansen, C Hamers, MJAG Johannessen, BE Brunner, N Stephens, RW
Citation: C. Holst-hansen et al., Soluble urokinase receptor released from human carcinoma cells: a plasma parameter for xenograft tumour studies, BR J CANC, 81(2), 1999, pp. 203-211
The urokinase plasminogen activation system in breast cancer
Authors: Pedersen, AN Holst-Hansen, C Frandsen, TL Nielsen, BS Stephens, RW Brunner, N
Citation: An. Pedersen et al., The urokinase plasminogen activation system in breast cancer, CONT CANC R, 3, 1999, pp. 325-345
A new immunocapture assay for Escherichia coli beta-galactosidase for in vivo studies of lacZ-transduced tumor cells
Authors: Holst-Hansen, C Brunner, N Johannessen, BE Felding, J Stephens, RW
Citation: C. Holst-hansen et al., A new immunocapture assay for Escherichia coli beta-galactosidase for in vivo studies of lacZ-transduced tumor cells, LAB INV, 78(12), 1998, pp. 1643-1644
Risultati: 1-7 |